The Patent Finder

Terms ending in 2040

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,459,916Substituted Indazoles Useful for Treatment and Prevention of Allergic And/Or Inflammatory Diseases in Animals
In force
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 11,667,675Masp Inhibitory Compounds and Uses Thereof
In force
 · High confidence
Bayer AktiengesellschaftIn forceHigh confidence
US 12,503,491Masp Inhibitory Compounds and Uses Thereof
In force
 · Medium confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 11,944,690Formulation of Contrast Media and Process of Preparation Thereof
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 12,059,472Prodrugs of Cytotoxic Active Agents Having Enzymatically Cleavable Groups
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,998,539Substituted Aminoquinolones as Dgkalpha Inhibitors for Immune Activation
In force
 · Medium confidence
Deutsches KrebsforschungszentrumIn forceMedium confidence
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited